Viewing StudyNCT06444204



Ignite Creation Date: 2024-06-16 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06444204
Status: COMPLETED
Last Update Posted: 2024-06-05
First Post: 2024-05-30

Brief Title: A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib PRN1008
Sponsor: Principia Biopharma a Sanofi Company
Organization: Sanofi

Conditions & Keywords Data

Conditions:
Name
Hepatic Function Abnormal
Healthy Volunteers
Keywords: